Amkor Technology CapEx decreased by 48.0% to $224.61M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 181.1%, from $79.90M to $224.61M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 3.8% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $163.27M | $217.81M | $288.35M | $158.15M | $182.05M | $235.29M | $332.79M | $98.22M | $184.09M | $229.35M | $237.81M | $96.17M | $166.37M | $195.52M | $285.73M | $79.90M | $146.19M | $246.45M | $432.08M | $224.61M |
| QoQ Change | — | +33.4% | +32.4% | -45.2% | +15.1% | +29.2% | +41.4% | -70.5% | +87.4% | +24.6% | +3.7% | -59.6% | +73.0% | +17.5% | +46.1% | -72.0% | +83.0% | +68.6% | +75.3% | -48.0% |
| YoY Change | — | — | — | — | +11.5% | +8.0% | +15.4% | -37.9% | +1.1% | -2.5% | -28.5% | -2.1% | -9.6% | -14.7% | +20.1% | -16.9% | -12.1% | +26.0% | +51.2% | +181.1% |